XML 38 R12.htm IDEA: XBRL DOCUMENT v3.24.4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock (1)
Additional Paid-In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021 [1]   226,199    
Beginning balance at Dec. 31, 2021 $ 38,722,985 $ 23 [1] $ 70,920,154 $ (32,197,192)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of equity securities, net (in shares) [1]   46,697    
Issuance of equity securities, net 1,984,876 $ 5 [1] 1,984,871  
Equity-based compensation (in shares) [1]   3,491    
Equity-based compensation expense 768,255   768,255  
Net loss (31,607,956)     (31,607,956)
Ending balance (in shares) at Dec. 31, 2022 [1],[2]   281,987    
Ending balance at Dec. 31, 2022 10,384,608 $ 28 [1],[2] 74,189,728 (63,805,148)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of equity securities, net (in shares) [2]   17,812    
Issuance of equity securities, net 311,681 $ 2 [2] 311,679  
Equity-based compensation (in shares) [2]   8,737    
Equity-based compensation expense 203,345 $ 1 [2] 203,344  
Net loss (5,340,773)     (5,340,773)
Ending balance (in shares) at Mar. 31, 2023 [2]   308,536    
Ending balance at Mar. 31, 2023 5,558,861 $ 31 [2] 74,704,751 (69,145,921)
Beginning balance (in shares) at Dec. 31, 2022 [1],[2]   281,987    
Beginning balance at Dec. 31, 2022 10,384,608 $ 28 [1],[2] 74,189,728 (63,805,148)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (11,660,897)      
Ending balance (in shares) at Sep. 30, 2023 [2]   492,304    
Ending balance at Sep. 30, 2023 6,083,703 $ 49 [2] 81,549,699 (75,466,045)
Beginning balance (in shares) at Dec. 31, 2022 [1],[2]   281,987    
Beginning balance at Dec. 31, 2022 10,384,608 $ 28 [1],[2] 74,189,728 (63,805,148)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of equity securities, net (in shares) [1]   201,580    
Issuance of equity securities, net 6,920,529 $ 20 [1] 6,920,509  
Equity-based compensation (in shares) [1]   8,737    
Equity-based compensation expense 524,838 $ 1 [1] 524,837  
Net loss $ (12,542,693)     (12,542,693)
Ending balance (in shares) at Dec. 31, 2023 492,304 492,304 [1],[2]    
Ending balance at Dec. 31, 2023 $ 5,287,282 $ 49 [1],[2] 81,635,074 (76,347,841)
Beginning balance (in shares) at Mar. 31, 2023 [2]   308,536    
Beginning balance at Mar. 31, 2023 5,558,861 $ 31 [2] 74,704,751 (69,145,921)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of equity securities, net (in shares) [2]   110,472    
Issuance of equity securities, net 6,608,790 $ 11 [2] 6,608,779  
Equity-based compensation expense 123,459   123,459  
Net loss (3,877,308)     (3,877,308)
Ending balance (in shares) at Jun. 30, 2023 [2]   419,008    
Ending balance at Jun. 30, 2023 8,413,802 $ 42 [2] 81,436,989 (73,023,229)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of equity securities, net (in shares) [2]   73,296    
Issuance of equity securities, net 59 $ 7 [2] 52  
Equity-based compensation expense 112,658   112,658  
Net loss (2,442,816)     (2,442,816)
Ending balance (in shares) at Sep. 30, 2023 [2]   492,304    
Ending balance at Sep. 30, 2023 $ 6,083,703 $ 49 [2] 81,549,699 (75,466,045)
Beginning balance (in shares) at Dec. 31, 2023 492,304 492,304 [1],[2]    
Beginning balance at Dec. 31, 2023 $ 5,287,282 $ 49 [1],[2] 81,635,074 (76,347,841)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of equity securities, net (in shares) [2]   47,000    
Issuance of equity securities, net 38 $ 5 [2] 33  
Equity-based compensation expense 77,508   77,508  
Net loss (1,715,290)     (1,715,290)
Ending balance (in shares) at Mar. 31, 2024 [2]   539,304    
Ending balance at Mar. 31, 2024 $ 3,649,538 $ 54 [2] 81,712,615 (78,063,131)
Beginning balance (in shares) at Dec. 31, 2023 492,304 492,304 [1],[2]    
Beginning balance at Dec. 31, 2023 $ 5,287,282 $ 49 [1],[2] 81,635,074 (76,347,841)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (4,111,844)      
Ending balance (in shares) at Sep. 30, 2024 1,441,157 1,441,157 [2]    
Ending balance at Sep. 30, 2024 $ 2,924,583 $ 144 [2] 83,384,124 (80,459,685)
Beginning balance (in shares) at Mar. 31, 2024 [2]   539,304    
Beginning balance at Mar. 31, 2024 3,649,538 $ 54 [2] 81,712,615 (78,063,131)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of equity securities, net (in shares) [2]   101,873    
Issuance of equity securities, net 65,080 $ 10 [2] 65,070  
Equity-based compensation expense 85,168   85,168  
Net loss (1,424,433)     (1,424,433)
Ending balance (in shares) at Jun. 30, 2024 [2]   641,177    
Ending balance at Jun. 30, 2024 2,375,353 $ 64 [2] 81,862,853 (79,487,564)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of equity securities, net (in shares) [2]   799,980    
Issuance of equity securities, net 1,461,342 $ 80 [2] 1,461,262  
Equity-based compensation expense 60,009   60,009  
Net loss $ (972,121)     (972,121)
Ending balance (in shares) at Sep. 30, 2024 1,441,157 1,441,157 [2]    
Ending balance at Sep. 30, 2024 $ 2,924,583 $ 144 [2] $ 83,384,124 $ (80,459,685)
[1] Share and per share amounts have been recast to reflect the 1-for-8 reverse stock split effected in June 14, 2024 on retroactive basis for all periods presented.
[2] Share and per share amounts have been restated to reflect the 1-for-8 reverse stock split effected in June 14, 2024 on retroactive basis for all periods presented.